Notice of Intent to Sole Source - USAMRDC/DHA Marketing Tool Subscription

The Defense Health Agency (DHA) has issued a Special Notice of Intent to Sole Source a marketing tool subscription for the U.S. Army Medical Research and Development Command (USAMRDC) and Defense Health Agency's Office of Research and Technology Applications (ORTA)/Medical Technology Transfer Office (MTT). The notice, published on April 17, 2025, indicates the agency's intention to award a contract to Global Action Alliance Inc for a 10-seat subscription to the WISE-R AI platform. The contract falls under NAICS category 518210 for Computing Infrastructure Providers and PSC code 7A20 for Application Development Software. USAMRAA, located at Fort Detrick, Maryland, asserts that Global Action Alliance Inc is the sole vendor capable of meeting their specific requirements for this technology.

The primary objective of this sole source procurement is to acquire an AI-powered tool that will assist licensing professionals in identifying potential biotechnology and pharmaceutical companies for licensing DHA intellectual property. The WISE-R platform will provide comprehensive commercial landscape analysis, including detailed insights such as patent information, clinical trial results, business details, company profiles, and contact points. Interested alternative vendors must submit written evidence of comparable service capabilities by May 2, 2025, to skylar.a.wells2.civ@health.mil to be considered. If no compelling alternative is presented, the contract will be awarded directly to Global Action Alliance Inc. The tool is specifically designed to support the advancement of medical research inventions into commercial products, with a focused approach on supporting technology transfer and commercialization efforts within the defense health research ecosystem.